GLP-1 drugs and eye health risks: A new watchlist for diabetes patients
(NaturalNews) GLP-1 drugs like Ozempic and Wegovy double the risk of neovascular age-related macular degeneration (wet AMD) in diabetes patients over three year…
ADA (American Diabetes Association) June 20-23 Obesity Medicines – Other Posters and Talks
🧪 NA‑931 (Bioglutide™) – Biomed Industries, Inc.Presentation (Oral):Title: “Phase 2 Clinical Trials of NA‑931, an Oral Novel Quadruple IGF‑1, GLP‑1, GIP, and Glucagon Receptor Agonist, Reduces Body Weight Without Muscle Loss.”Presenter: Dr. Lloyd L. Tran (CEO)Date & Time: June 20, 2025 – oral session (specific time TBD at conference)Poster:Title: “Association Between Alzheimer’s Disease (AD) and Obesity: Clinical Trial […]
Court upholds FDA removal of semaglutide from drug shortage list
A federal judge in Texas has upheld the FDA’s decision to remove GLP-1 drugs, including Novo Nordisk’s Ozempic and Wegovy, from its drug shortage list, rejecting a bid by compounding pharmacies to allow them to continue making copies of the drugs, The Hill reported June 18. U.S. District Judge Mark Pittmann ruled June 17 that […]
GLP-1 Use in Europe Hampered by Stigma and Cost
At HLTH Europe 2025, experts warned that stigma, cost barriers, and lack of support are hindering the wider use of GLP-1s in European healthcare systems. Medscape Medical News
Telling the Good from the Bad Compounded GLP-1 Drugs
The surge in demand for GLP-1 medicines has led to a market made up of compounded versions sold online. While compounding pharmacies are essential for patients who can’t medically tolerate FDA-approved drugs or helping to alleviate shortages, the rise of compounded GLP-1s indicates a troubling oversight issue as distinguishing good actors from bad ones is […]
Omada Health Data Shows Companion Program Significantly Boosts GLP-1 Medication Persistence
What You Should Know: – Omada Health, the virtual between-visit healthcare provider released new data demonstrating that its GLP-1 companion program significantly improves persistence rates for GLP-1 medications. – The analysis found that members in Omada’s program achieved weight loss results similar to those seen in controlled research settings, underscoring the importance of comprehensive support […]
Influencer Reacts to Criticism ‘Ozempic Is Cheating’ After GLP-1 Weight Loss
Wellness influencer Janelle Rohner has seen the internet’s criticism after revealing she micro-dosed GLP-1 to lose weight. “‘Ozempic is cheating.’ ‘Ozempic is the easy way out,’” Rohner wrote via Instagram on Tuesday, June 17. “Here is my experience: You still need to prioritize macros, especially protein and fiber you need to continue to fuel your […]
FDA’s removal of Ozempic, Wegovy from drug shortage list upheld
A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the drugs, was lawful and that the agency acted correctly. U.S. District Court Judge Mark Pittman found that the Outsourcing Facilities Association (OFA), an organization […]
Oxytocin stimulates pancreatic hormones to improve insulin secretion
A new research paper was published in Aging (Aging-US) Volume 17, Issue 5, on May 1, 2025, titled “Oxytocin modulates insulin and GLP-1 secretion in pancreatic islets.”
Is Ozempic Better Than Weight Loss Surgery?
GLP-1 drugs are the hot new kid on the weight loss scene, and for good reason. They appear to help people shed pounds by suppressing appetites and managing caloric intake. However, a new real-world study presented at the American Society for Metabolic and Bariatric Surgery’s 2025 scientific meeting has revealed a significant gap between the hype surrounding […]